Quest Diagnostics

NYSE: DGX · Real-Time Price · USD
179.45
1.01 (0.57%)
At close: Aug 15, 2025, 11:58 AM

Quest Diagnostics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
921M 908M 1.01B 2.08B
Depreciation & Amortization
493M 439M 437M 408M
Stock-Based Compensation
88M 77M 77M 79M
Other Working Capital
-63M -75M 22M -9M
Other Non-Cash Items
20M 42M 69M -364M
Deferred Income Tax
13M -49M 1M -57M
Change in Working Capital
-201M -145M 119M 87M
Operating Cash Flow
1.33B 1.27B 1.72B 2.23B
Capital Expenditures
-425M -408M -404M -403M
Cash Acquisitions
-2.16B -611M -144M 424M
Purchase of Investments
n/a n/a -5M -3M
Sales Maturities Of Investments
n/a n/a 5M 403M
Other Investing Acitivies
41M -42M 5M -400M
Investing Cash Flow
-2.55B -1.06B -543M 21M
Debt Repayment
1.54B 748M -2M -2M
Common Stock Repurchased
-151M -275M -1.41B -2.2B
Dividend Paid
-331M -314M -305M -309M
Other Financial Acitivies
23M 1M -17M -30M
Financial Cash Flow
1.08B 160M -1.73B -2.54B
Net Cash Flow
-137M 371M -557M -286M
Free Cash Flow
909M 864M 1.31B 1.83B